Pharmexcil · DGCI&S · Ministry of Commerce · IBEF · 2004–2026
22 years of pharmaceutical export data — tracking how India grew from a $3.7 Bn exporter in FY2004 to the world's largest supplier of generic medicines, exporting to 200+ countries with a target of $65 Bn by 2030.
Exports FY2004
$3.7 Bn
Baseline yearExports FY2026
$27.9 Bn
Pharmexcil est.22-yr CAGR
~10.1%
Compound annualPeak Export Year
FY2022
$24.6 Bn · Post-COVIDGlobal Generics Share
~20%
By volumeExport Countries
200+
Global reachIndia Pharmaceutical Exports · FY2004–FY2026
Annual export value in USD Billion · Pharmexcil / DGCI&S data
Decade-wise Comparison
Average annual exports: 2004–13 vs 2014–19 vs 2020–26
Share of India's Total Merchandise Exports
Pharma as % of total goods exports · rising strategic importance
Formulations (Finished Drugs)
~75% of total exports (~$20.9 Bn in FY2026). Tablets, capsules, injectables shipped to regulated & semi-regulated markets. US, UK, EU are key destinations.
Bulk Drugs / APIs
~18% of exports (~$5.0 Bn). India supplies 57% of the world's API demand. Key ingredients for global pharma supply chains.
Biologics & Vaccines
~7% and growing. India supplies 60% of global vaccine demand. Serum Institute alone exports to 170+ countries. Fastest-growing sub-segment.
Segment Mix · FY2026
Formulations dominate; API share stable; biologics rising fast
Formulations vs APIs · Historical Split
How the segment balance has evolved over time
Top 8 Export Destinations · FY2026
Value in USD Billion · US dominates at ~25%
2004–2010: Foundation Era
India established TRIPS-compliant generic manufacturing. Exports grew from $3.7 Bn to $9.8 Bn, building footprint in Africa and semi-regulated markets.
2011–2015: US Market Push
ANDA filings surged. India captured ~35% of all US generic approvals. Exports crossed $15 Bn. Domestic formulation companies went global.
2016–2019: Quality & Consolidation
FDA import alerts slowed growth. Industry invested heavily in compliance and quality upgrades. Exports plateaued at $17–19 Bn range.
2020–2022: COVID Surge
India exported HCQ, remdesivir and vaccines globally. Serum Institute became world-largest vaccine maker. Exports hit record $24.6 Bn in FY2022.